The worldwide IVC Filter market has recently been published by Absolute Markets Insights. The statistical report offers an appropriate analysis of recent trends and technological advancements in global regions such as North America, Latin America, Asia-Pacific, Africa, and India. The data also uses useful tools, methodologies and standard operating procedures carried out by top-level industries to support its analysis. Moreover, the study also applies effective exploratory techniques such as primary and secondary research techniques. Some of the distinctive market key components of the global IVC Filter market have been studied in order to get an extensive idea about the requirements of the businesses. Financial and economic aspects of the businesses have also been presented by means of graphical presentation techniques such as charts, graphs, tables, and pictures. The entire demand and supply chain has been explained with the help of penetrative insights into the businesses.
Top Players of Global IVC Filter Market are Studied: Boston Scientific, Cardinal Health, Cook Medical, C. R. Bard, Argon Medical Devices, Inc., Volcano Corporation (Philips Volcano), ALN, B.Braun (B. Braun Melsungen AG), Braile Biomédica, VENITI, Inc., Adient Medical Inc. amongst others.
Click to view the full report: https://www.absolutemarketsinsights.com/reports/IVC-Filter-Market-2018-2026-83
The global IVC filter market was valued to be US$ 603.2 Mn in 2020 and is anticipated to be US$ 1036.5+ Mn by 2030.
The inferior vena cava (IVC) is the largest vein, that carries blood from the lower part of the body to the heart for purification. But sometimes along with blood, the vein also carries large blood clots to the heart which may further lead to problems such as pulmonary embolism or blockage. To prevent this condition, IVC filters are placed within the IVC. They trap large clots present in the veins and thus prevent blood clots from reaching the heart and lungs. They are used as an alternative treatment for patients who do not respond to blood thinners. The U.S. Food and Drug Administration (FDA) approved the usage of IVC filter in 1979. Since then their usage has increased three-fold. Traditionally, they were available as permanent implantable devices. But now due to technology advancement, they can either be placed permanently or removed from the blood vessel later. Patients suffering from deep vein thrombosis and pulmonary embolus usually opt for the implant.
The region of North America has been dominating the IVC filter market in past. The number of IVC filters placed in the U.S. has increased by 234%, from 56, 380 in 2000 to 132, 049 in 2009. As per the Society for Vascular Surgery, 84% of the U.S. patients suffering with deep vein thrombosis and pulmonary embolism opt for filter implants as compared to consuming blood thinners. Largest number of IVC filters were implanted in the urban hospitals of Southern region followed by the Northeastern and Western Region. The largest utilization of IVC filters was among patients aged 50 to 79 years and in the Southern region of the U.S.
By Types:
- Retrievable
- Permanent
By Application:
- Treatment of Venous Thromboembolism
- Prevention of Pulmonary Embolism
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
No comments:
Post a Comment